First Study Of Its Kind Questions Whether People Called For Jury Service Should Be Screened To Avoid ‘Trauma’

Posted by poster | Uncategorized | Tuesday 31 March 2009 6:36 pm

A new report by psychologists at the University of Leicester warns of the dangers of jurors facing trauma because of their exposure to harrowing and gruesome evidence.
In the first study of its kind, the research highlights how women jurors are more vulnerable, particularly if the trial covers material that resonates with their personal histories.
The research confirms that jury service, particularly (more…)

New Strategy To Weaken Traumatic Memories

Posted by poster | Uncategorized | Tuesday 31 March 2009 2:39 pm

Imagine that you have been in combat and that you have watched your closest friend die in front of you. The memory of that event may stay with you, troubling you for the rest of your life. Posttraumatic stress disorder (PTSD) is among the most common and disabling psychiatric casualties of combat and other extremely stressful situations. People suffering from PTSD often suffer from vivid intrusive memories of their traumas. Current (more…)

Food Allergies Limit Where And How Families Vacation

Posted by poster | Uncategorized | Monday 30 March 2009 12:35 am

Families with food allergic individuals make significant lifestyle alterations when it comes to vacation planning, according to a study presented at the 2009 Annual Meeting of the American Academy (more…)

Female Cardiovascular Patients With Depression Incur Higher Health Care Costs

Posted by poster | Uncategorized | Friday 13 March 2009 5:46 am

Women with suspected coronary artery disease who suffer from depression have significantly higher health care costs than those who are not depressed, according to findings from the Women’s Ischemia Syndrome Evaluation (WISE), an ongoing, multicenter study funded (more…)

Evotec And Roche To Develop EVT 101 For Treatment-Resistant Depression

Posted by poster | Uncategorized | Wednesday 11 March 2009 7:35 pm

Evotec AG (Frankfurt Stock Exchange: EVT; NASDAQ: EVTC) and Roche (SWX: RO, ROG; OTCQX: RHHBY) announced today that they have entered into an agreement for Phase II clinical development of EVT 101 in patients with treatment-resistant depression. The potential value of this transaction exceeds USD 300 million.
Evotec will be responsible for conducting Phase II studies for EVT 101, a compound originally discovered by Roche and (more…)

Side Effects Of Chantix For Smoking Cessation No Worse With Depression History

Posted by poster | Uncategorized | Tuesday 10 March 2009 8:35 am

People with a likely history of depression who take varenicline (Chantix®) do not report more severe mood symptoms, medication side effects, or less success quitting smoking compared to people with no history of depression taking this drug.
The findings by Group Health, Free & Clear, and SRI International researchers are reported in a Journal of General Internal Medicine article published online. The National Cancer Institute (more…)

HSE Launches New Website To Prevent Work-related Stress

Posted by poster | Uncategorized | Monday 9 March 2009 12:35 am

The Health and Safety Executive (HSE) today unveiled a new stress website that will help businesses prevent work-related stress.
The website includes updated advice and guidance, tools to help prevent stress at work, a self-assessment questionnaire for line managers, case studies and good practical examples of things that have worked well for other organisations. The focus (more…)

Wide Range Of Human Health And Environment Topical Sessions To Be Featured In Toxicology Program

Posted by poster | Uncategorized | Sunday 8 March 2009 12:35 am

Nearly 6,500 toxicologists from around the world will be gathering in Baltimore, Maryland March 15-19, to create an unparalleled venue for discussion of a number of health and environmental topics of concern (more…)